HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Bordignon Selected Research

asparagine-glycine-arginine

1/2013Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours.
6/2012Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients.
4/2011Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies.
7/2009Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Bordignon Research Topics

Disease

6Necrosis
07/2013 - 07/2009
4Hematologic Neoplasms (Hematological Malignancy)
06/2015 - 01/2005
3Graft vs Host Disease (Graft-Versus-Host Disease)
02/2015 - 03/2001
2Leukemia
06/2015 - 05/2015
2Neoplasms (Cancer)
05/2015 - 07/2000
1Infections
09/2015
1Ovarian Neoplasms (Ovarian Cancer)
06/2012
1Colorectal Neoplasms (Colorectal Cancer)
04/2011
1Hematologic Diseases (Blood Diseases)
11/2010
1Hepatocellular Carcinoma (Hepatoma)
09/2010
1Disease Progression
08/2005
1Herpes Simplex
08/2005
1Hypoglycemia (Reactive Hypoglycemia)
11/2002
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2002
1Tay-Sachs Disease
08/2002
1Mucopolysaccharidosis IV (Morquio Syndrome)
11/2001
1Metachromatic Leukodystrophy (Sulfatide Lipidosis)
03/2001
1Lipidoses
03/2001

Drug/Important Bio-Agent (IBA)

5Peptides (Polypeptides)IBA
07/2013 - 07/2000
5human CNGRC fusion protein tumor necrosis factor-alphaIBA
01/2013 - 07/2009
4asparagine-glycine-arginineIBA
01/2013 - 07/2009
3HLA Antigens (Human Leukocyte Antigens)IBA
05/2015 - 11/2008
2Sirolimus (Rapamycin)FDA Link
06/2015 - 02/2015
2Calcineurin InhibitorsIBA
06/2015 - 02/2015
2CD13 Antigens (Alanine Aminopeptidase)IBA
09/2010 - 07/2009
1Biomarkers (Surrogate Marker)IBA
09/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2012
1Capecitabine (Xeloda)FDA Link
04/2011
1XELOXIBA
04/2011
1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2011
1EnzymesIBA
08/2005
1Hexosaminidases (Hexosaminidase)IBA
08/2005
1Hexosaminidase A (Hex A)IBA
08/2005
1Insulin (Novolin)FDA Link
11/2002
1G(M2) Ganglioside (Ganglioside GM2)IBA
08/2002
1SulfatasesIBA
11/2001
1Complementary DNA (cDNA)IBA
11/2001
1Cerebroside-Sulfatase (Arylsulfatase A)IBA
03/2001
1Neoplasm Antigens (Tumor Antigens)IBA
07/2000
1Amino AcidsFDA Link
07/2000
1AntigensIBA
07/2000

Therapy/Procedure

4Hematopoietic Stem Cell Transplantation
09/2015 - 11/2010
4Therapeutics
06/2015 - 08/2002
2Stem Cell Transplantation
11/2008 - 01/2005
1Transplantation
05/2015
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
02/2015
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2001
1Immunotherapy
07/2000